Chordia Therapeutics,Inc Logo

Chordia Therapeutics,Inc

Clinical-stage biotech developing novel cancer therapies targeting RNA deregulation.

190A | T

Overview

Corporate Details

ISIN(s):
JP3283730004
LEI:
Country:
Japan
Address:
藤沢市村岡東2−26−1

Description

Chordia Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the research and development of novel cancer therapies. The company focuses on discovering and developing first-in-class, small-molecule drugs that target RNA deregulation, a key driver in various cancers. Its mission is to create life-changing treatments for patients by advancing a pipeline of innovative drug candidates from preclinical research through clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-21 05:00
確認書
Japanese ZIP 8.1 KB
2025-11-21 05:00
有価証券報告書-第8期(2024/09/01-2025/08/31)
Japanese ZIP 2.6 MB
2025-09-05 08:30
有価証券届出書(参照方式)
Japanese ZIP 534.8 KB
2025-05-16 02:45
臨時報告書
Japanese ZIP 20.2 KB
2025-04-11 04:50
半期報告書-第8期(2024/09/01-2025/08/31)
Japanese ZIP 144.4 KB
2025-04-11 04:50
確認書
Japanese ZIP 8.1 KB
2024-12-17 07:30
訂正確認書
Japanese ZIP 8.7 KB
2024-11-29 07:37
臨時報告書
Japanese ZIP 23.1 KB
2024-11-29 07:36
確認書
Japanese ZIP 8.1 KB
2024-11-29 07:35
内部統制報告書-第7期(2023/09/01-2024/08/31)
Japanese ZIP 21.2 KB
2024-11-29 07:34
有価証券報告書-第7期(2023/09/01-2024/08/31)
Japanese ZIP 2.8 MB
2024-07-16 06:55
四半期報告書-第7期第3四半期(2024/03/01-2024/05/31)
Japanese ZIP 123.4 KB
2024-07-16 06:55
確認書
Japanese ZIP 8.0 KB
2024-06-06 08:00
訂正有価証券届出書(新規公開時)
Japanese ZIP 2.9 MB
2024-05-29 04:00
訂正有価証券届出書(新規公開時)
Japanese ZIP 2.9 MB

Automate Your Workflow. Get a real-time feed of all Chordia Therapeutics,Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chordia Therapeutics,Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chordia Therapeutics,Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.